Gamco, Gabelli reduce stake in Exactech

By Lisa Kerner

Charlotte, N.C., Feb. 11 - Exactech, Inc. investors led by Gamco Asset Management Inc. and Gabelli Funds, LLC sold 73,500 shares of the company's stock.

The shares were sold between Dec. 19 and Feb. 2 priced from $20.36 to $23.92 per share.

The investors beneficially own 816,146 shares, or 7.04%, of Exactech's outstanding stock, according to a schedule 13D filing with the Securities and Exchange Commission.

Based in Gainesville, Fla., Exactech develops orthopedic implant devices, related surgical instruments and biologic materials.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.